These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27509669)

  • 1. [Not Available].
    Ye F; Lecourt S; Vernochet A; Durrbach A
    Bull Acad Natl Med; 2015; 199(4-5):515-23. PubMed ID: 27509669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Therapy in Solid-Organ Transplant.
    Argani H
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):6-13. PubMed ID: 27805502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stromal Cells in Solid Organ Transplantation.
    Vandermeulen M; Erpicum P; Weekers L; Briquet A; Lechanteur C; Detry O; Beguin Y; Jouret F
    Transplantation; 2020 May; 104(5):923-936. PubMed ID: 31929427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation.
    Reinders ME; Rabelink TJ; de Fijter JW
    Curr Opin Organ Transplant; 2013 Feb; 18(1):44-50. PubMed ID: 23254697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance.
    Franquesa M; Hoogduijn MJ; Baan CC
    Curr Opin Organ Transplant; 2012 Aug; 17(4):355-61. PubMed ID: 22710385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
    Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
    Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of mesenchymal stromal cells in solid organ transplantation].
    Delens L; Jouret F; Detry O; Beguin Y; Krzesinski JM
    Rev Med Suisse; 2014 Aug; 10(439):1538, 1540-3. PubMed ID: 25272670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical translation of multipotent mesenchymal stromal cells in transplantation.
    Leuning DG; Reinders ME; de Fijter JW; Rabelink TJ
    Semin Nephrol; 2014 Jul; 34(4):351-64. PubMed ID: 25217264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
    Ringdén O
    Stem Cells Dev; 2009 Nov; 18(9):1243-6. PubMed ID: 19905962
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesenchymal stromal cells: potential roles in graft-versus-host disease prophylaxis and treatment.
    Maziarz RT
    Transfusion; 2016 Apr; 56(4):9S-14S. PubMed ID: 27079324
    [No Abstract]   [Full Text] [Related]  

  • 13. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
    Perico N; Casiraghi F; Gotti E; Introna M; Todeschini M; Cavinato RA; Capelli C; Rambaldi A; Cassis P; Rizzo P; Cortinovis M; Noris M; Remuzzi G
    Transpl Int; 2013 Sep; 26(9):867-78. PubMed ID: 23738760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory Cells: Can They Be Harnessed for Transplant?
    Pullen LC
    Am J Transplant; 2019 Feb; 19(2):309-310. PubMed ID: 30690909
    [No Abstract]   [Full Text] [Related]  

  • 15. Mesenchymal stem cells in organ and tissue transplantation: one for all seasons?
    Eggenhofer E
    Curr Opin Organ Transplant; 2013 Feb; 18(1):22-3. PubMed ID: 23222175
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of bone marrow mesenchymal stem cells overexpressing heme oxygenase-1: Protective effects on acute rejection following reduced-size liver transplantation in a rat model.
    Shen ZY; Wu B; Liu T; Yang Y; Yin ML; Zheng WP; Zhang BY; Song HL
    Cell Immunol; 2017 Mar; 313():10-24. PubMed ID: 28069109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.
    Ben Nasr M; Vergani A; Avruch J; Liu L; Kefaloyianni E; D'Addio F; Tezza S; Corradi D; Bassi R; Valderrama-Vasquez A; Usuelli V; Kim J; Azzi J; El Essawy B; Markmann J; Abdi R; Fiorina P
    Acta Diabetol; 2015 Oct; 52(5):917-27. PubMed ID: 25808641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation.
    Casiraghi F; Noris M; Remuzzi G
    Curr Opin Organ Transplant; 2010 Dec; 15(6):731-7. PubMed ID: 20881495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.